Evidence map›Paper›PMID 26921030›Full record

ArticleJournal of biomolecular NMR2016

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.

Aleksandar Antanasijevic, Carolyn Kingsley, Arnab Basu, Terry L Bowlin, Lijun Rong, Michael Caffrey

Open access · greenAbstract read
In one paragraph

Article in Journal of biomolecular NMR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Virus-Glycan Interactions Studied by Solute NMR.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Article
  4. VLP-Based Model for Study of Airborne Viral Pathogens.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery.Journal of enzyme inhibition and medicinal chemistry · 2019
    Article
  7. Article
  8. Probing the metastable state of influenza hemagglutinin.The Journal of biological chemistry · 2017
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Aleksandar AntanasijevicDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S Ashland, Chicago, IL, 60607, USA.
Carolyn KingsleyDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S Ashland, Chicago, IL, 60607, USA.
Arnab BasuMicrobiotix Inc., Worcester, MA, 01605, USA.
Terry L BowlinMicrobiotix Inc., Worcester, MA, 01605, USA.
Lijun RongDepartment of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Michael CaffreyDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S Ashland, Chicago, IL, 60607, USA. caffrey@uic.edu.
Ashland (United States) · USMicrobiotix (United States) · USUniversity of Illinois Chicago · US

Funding

Identification of Novel Broad Spectrum Influenza Virus InhibitorsR44AI072861 · NIAID · MICROBIOTIX, INC · PI BASU, ARNAB · 2012 to 2014
$2.9M
NMR-based discovery of influenza hemagglutinin probesR21AI101676 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CAFFREY, MICHAEL S. · 2012 to 2013
$427k
NIAID NIH HHS 1R21AI101676NIAID NIH HHS 5R44AI072861NIAID NIH HHS R21 AI101676NIAID NIH HHS R44 AI072861
6 · The paper itself

Abstract

The membrane proteins of viruses play critical roles in the virus life cycle and are attractive targets for therapeutic intervention. Virus-like particles (VLP) present the possibility to study the biochemical and biophysical properties of viral membrane proteins in their native environment. Specifically, the VLP constructs contain the entire protein sequence and are comprised of native membrane components including lipids, cholesterol, carbohydrates and cellular proteins. In this study we prepare VLP containing full-length hemagglutinin (HA) or neuraminidase (NA) from influenza and characterize their interactions with small molecule inhibitors. Using HA-VLP, we first show that VLP samples prepared using the standard sucrose gradient purification scheme contain significant amounts of serum proteins, which exhibit high potential for non-specific interactions, thereby complicating NMR studies of ligand-target interactions. We then show that the serum contaminants may be largely removed with the addition of a gel filtration chromatography step. Next, using HA-VLP we demonstrate that WaterLOGSY NMR is significantly more sensitive than Saturation Transfer Difference (STD) NMR for the study of ligand interactions with membrane bound targets. In addition, we compare the ligand orientation to HA embedded in VLP with that of recombinant HA by STD NMR. In a subsequent step, using NA-VLP we characterize the kinetic and binding properties of substrate analogs and inhibitors of NA, including study of the H274Y-NA mutant, which leads to wide spread resistance to current influenza antivirals. In summary, our work suggests that VLP have high potential to become standard tools in biochemical and biophysical studies of viral membrane proteins, particularly when VLP are highly purified and combined with control VLP containing native membrane proteins.

Indexed as

Nuclear Magnetic Resonance, BiomolecularCell LineHemagglutinin Glycoproteins, Influenza VirusHumansKineticsMutant ProteinsNeuraminidaseProtein BindingViral Matrix ProteinsHemagglutinin Glycoproteins, Influenza VirusMutant ProteinsNeuraminidaseViral Matrix ProteinsAntiviral agentDrug resistanceInfluenzaSTDVirus entryWaterLOGSY

Identifiers

PMID26921030
PMCPMC4826305
OpenAlexW2290724261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.